Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls.

Unger MM, Spiegel J, Dillmann KU, Grundmann D, Philippeit H, Bürmann J, Faßbender K, Schwiertz A, Schäfer KH.

Parkinsonism Relat Disord. 2016 Nov;32:66-72. doi: 10.1016/j.parkreldis.2016.08.019. Epub 2016 Aug 26.

PMID:
27591074
2.

Gut microbiota are related to Parkinson's disease and clinical phenotype.

Scheperjans F, Aho V, Pereira PA, Koskinen K, Paulin L, Pekkonen E, Haapaniemi E, Kaakkola S, Eerola-Rautio J, Pohja M, Kinnunen E, Murros K, Auvinen P.

Mov Disord. 2015 Mar;30(3):350-8. doi: 10.1002/mds.26069. Epub 2014 Dec 5.

PMID:
25476529
3.

Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism.

Morrison DJ, Preston T.

Gut Microbes. 2016 May 3;7(3):189-200. doi: 10.1080/19490976.2015.1134082. Epub 2016 Mar 10. Review.

4.

More than constipation - bowel symptoms in Parkinson's disease and their connection to gut microbiota.

Mertsalmi TH, Aho VTE, Pereira PAB, Paulin L, Pekkonen E, Auvinen P, Scheperjans F.

Eur J Neurol. 2017 Nov;24(11):1375-1383. doi: 10.1111/ene.13398. Epub 2017 Sep 11.

PMID:
28891262
5.

Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson's disease patients.

Bedarf JR, Hildebrand F, Coelho LP, Sunagawa S, Bahram M, Goeser F, Bork P, Wüllner U.

Genome Med. 2017 Apr 28;9(1):39. doi: 10.1186/s13073-017-0428-y. Erratum in: Genome Med. 2017 Jun 29;9(1):61.

6.

Intestinal Microbiota and Microbial Metabolites Are Changed in a Pig Model Fed a High-Fat/Low-Fiber or a Low-Fat/High-Fiber Diet.

Heinritz SN, Weiss E, Eklund M, Aumiller T, Louis S, Rings A, Messner S, Camarinha-Silva A, Seifert J, Bischoff SC, Mosenthin R.

PLoS One. 2016 Apr 21;11(4):e0154329. doi: 10.1371/journal.pone.0154329. eCollection 2016.

7.

Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid-Producing Microbiota in the Gut.

de la Cuesta-Zuluaga J, Mueller NT, Corrales-Agudelo V, Velásquez-Mejía EP, Carmona JA, Abad JM, Escobar JS.

Diabetes Care. 2017 Jan;40(1):54-62. doi: 10.2337/dc16-1324. Epub 2016 Nov 14.

PMID:
27999002
8.

The Gut and Nonmotor Symptoms in Parkinson's Disease.

Klingelhoefer L, Reichmann H.

Int Rev Neurobiol. 2017;134:787-809. doi: 10.1016/bs.irn.2017.05.027. Epub 2017 Jul 3. Review.

PMID:
28805583
9.

Altered fecal short chain fatty acid composition in children with a history of Hirschsprung-associated enterocolitis.

Demehri FR, Frykman PK, Cheng Z, Ruan C, Wester T, Nordenskjöld A, Kawaguchi A, Hui TT, Granström AL, Funari V, Teitelbaum DH; HAEC Collaborative Research Group.

J Pediatr Surg. 2016 Jan;51(1):81-6. doi: 10.1016/j.jpedsurg.2015.10.012. Epub 2015 Oct 22.

10.

Gut dysfunction in Parkinson's disease.

Mukherjee A, Biswas A, Das SK.

World J Gastroenterol. 2016 Jul 7;22(25):5742-52. doi: 10.3748/wjg.v22.i25.5742. Review.

11.
12.

Colonic bacterial composition in Parkinson's disease.

Keshavarzian A, Green SJ, Engen PA, Voigt RM, Naqib A, Forsyth CB, Mutlu E, Shannon KM.

Mov Disord. 2015 Sep;30(10):1351-60. doi: 10.1002/mds.26307. Epub 2015 Jul 16.

PMID:
26179554
13.

Brain-gut-microbiota axis in Parkinson's disease.

Mulak A, Bonaz B.

World J Gastroenterol. 2015 Oct 7;21(37):10609-20. doi: 10.3748/wjg.v21.i37.10609. Review.

14.

Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease.

Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, Challis C, Schretter CE, Rocha S, Gradinaru V, Chesselet MF, Keshavarzian A, Shannon KM, Krajmalnik-Brown R, Wittung-Stafshede P, Knight R, Mazmanian SK.

Cell. 2016 Dec 1;167(6):1469-1480.e12. doi: 10.1016/j.cell.2016.11.018.

15.

Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity.

Remely M, Aumueller E, Merold C, Dworzak S, Hippe B, Zanner J, Pointner A, Brath H, Haslberger AG.

Gene. 2014 Mar 1;537(1):85-92. doi: 10.1016/j.gene.2013.11.081. Epub 2013 Dec 8.

PMID:
24325907
16.

Pediatric obesity is associated with an altered gut microbiota and discordant shifts in Firmicutes populations.

Riva A, Borgo F, Lassandro C, Verduci E, Morace G, Borghi E, Berry D.

Environ Microbiol. 2017 Jan;19(1):95-105. doi: 10.1111/1462-2920.13463. Epub 2016 Aug 22.

17.

The impact of long-term dietary pattern of fecal donor on in vitro fecal fermentation properties of inulin.

Yang J, Rose DJ.

Food Funct. 2016 Apr;7(4):1805-13. doi: 10.1039/c5fo00987a.

PMID:
26583778
18.

Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.

Sun MF, Shen YQ.

Ageing Res Rev. 2018 Apr 26;45:53-61. doi: 10.1016/j.arr.2018.04.004. [Epub ahead of print] Review.

PMID:
29705121
19.

Rapid and Sustained Long-Term Decrease of Fecal Short-Chain Fatty Acids in Critically Ill Patients With Systemic Inflammatory Response Syndrome.

Yamada T, Shimizu K, Ogura H, Asahara T, Nomoto K, Yamakawa K, Hamasaki T, Nakahori Y, Ohnishi M, Kuwagata Y, Shimazu T.

JPEN J Parenter Enteral Nutr. 2015 Jul;39(5):569-77. doi: 10.1177/0148607114529596. Epub 2014 Apr 7.

PMID:
24711120
20.

Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome.

Hill-Burns EM, Debelius JW, Morton JT, Wissemann WT, Lewis MR, Wallen ZD, Peddada SD, Factor SA, Molho E, Zabetian CP, Knight R, Payami H.

Mov Disord. 2017 May;32(5):739-749. doi: 10.1002/mds.26942. Epub 2017 Feb 14.

Supplemental Content

Support Center